↓ Skip to main content

The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K+-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure

Overview of attention for article published in BMC Nephrology, July 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
5 X users
facebook
1 Facebook page

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K+-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure
Published in
BMC Nephrology, July 2021
DOI 10.1186/s12882-021-02439-2
Pubmed ID
Authors

Daniel Murphy, Irina Chis Ster, Juan-Carlos Kaski, Lisa Anderson, Debasish Banerjee

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 10%
Student > Bachelor 4 8%
Student > Master 4 8%
Student > Ph. D. Student 3 6%
Unspecified 2 4%
Other 5 10%
Unknown 27 54%
Readers by discipline Count As %
Medicine and Dentistry 12 24%
Nursing and Health Professions 4 8%
Unspecified 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Psychology 1 2%
Other 3 6%
Unknown 27 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2021.
All research outputs
#14,391,096
of 23,507,405 outputs
Outputs from BMC Nephrology
#1,193
of 2,535 outputs
Outputs of similar age
#213,509
of 440,515 outputs
Outputs of similar age from BMC Nephrology
#28
of 59 outputs
Altmetric has tracked 23,507,405 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,535 research outputs from this source. They receive a mean Attention Score of 4.8. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.